Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy

IntroductionGender-affirming hormone therapy (GAHT) and gender-affirming surgery (GAS) may be desired by transgender and gender-diverse (TGD) individuals who want to affirm their gender identity. Testosterone is the basis of GAHT for transgender individuals assigned female at birth (AFAB), whereas G...

詳細記述

書誌詳細

主要な著者:	Elena Sanna, Alessandra Lami, Giulia Giacomelli, Stefania Alvisi, Alexandro Paccapelo, Renato Seracchioli, Maria Cristina Meriggiola
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2024-09-01
シリーズ:	Frontiers in Endocrinology
主題:	bone health transgender assigned female at birth (AFAB) testosterone Dual-energy X-ray absorptiometry (DXA) gender affirming hormonal therapy (GAHT)
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1416121/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!